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Background: While most resources in biofuels were directed towards implementing bioethanol programs,
1-propanol has recently received attention as a promising alternative biofuel. Nevertheless, no microorganism
has been identified as a natural 1-propanol producer. In this study, we manipulated a novel metabolic pathway
for the synthesis of 1-propanol in the genetically tractable bacterium Escherichia coli.
Results: E. coli strains capable of producing heterologous 1-propanol were engineered by extending the
dissimilation of succinate via propionyl-CoA. This was accomplished by expressing a selection of key genes, i.e.
(1) three native genes in the sleeping beauty mutase (Sbm) operon, i.e. sbm-ygfD-ygfG from E. coli, (2) the genes
encoding bifunctional aldehyde/alcohol dehydrogenases (ADHs) from several microbial sources, and (3) the sucCD
gene encoding succinyl-CoA synthetase from E. coli. Using the developed whole-cell biocatalyst under anaerobic
conditions, production titers up to 150 mg/L of 1-propanol were obtained. In addition, several genetic and
chemical effects on the production of 1-propanol were investigated, indicating that certain host-gene deletions
could abolish 1-propanol production as well as that the expression of a putative protein kinase (encoded by ygfD/
argK) was crucial for 1-propanol biosynthesis.
Conclusions: The study has provided a novel route for 1-propanol production in E. coli, which is subjected to
further improvement by identifying limiting conversion steps, shifting major carbon flux to the productive pathway,
and optimizing gene expression and culture conditions.
Keywords: Bifunctional aldehyde/alcohol dehydrogenases, Cyanocobalamin, Metabolic engineering, Methylmalonyl-
CoA mutases, Propanol, Propionate, Sleeping beauty mutase operonBackground
The majority of the world’s energy requirements are cur-
rently met through unfettered use of carbonaceous fossil
fuels. However, mounting environmental and socioeco-
nomic concerns associated with exploiting these resources
have led to the exploration of more sustainable and envir-
onmentally friendly energy forms, in particular biofuels [1].
While ethanol, one of the most common and successful
biofuels today, almost possesses established economic ni-
ches within energy markets, significant attention is being
directed towards the production of longer-chain alcohols,* Correspondence: cpchou@uwaterloo.ca
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reproduction in any medium, provided the orsuch as 1-butanol and 1-propanol [2,3]. These longer-chain
alcohols tend to have a higher energy content, lower hygro-
scopicity, and water solubility; and are compatible with
existing transportation infrastructures and pipelines [4].
In addition to being a potential biofuel, 1-propanol
serves as an important solvent and chemical for relevant
industrial applications [5]. Up to now, the production of
1-propanol primarily relies on chemical synthesis and no
microbial cells have been identified as a natural 1-
propanol producer. Nevertheless, recent advances in syn-
thetic biology and metabolic engineering have enabled
biological production of 1-propanol using various non-
natural but genetically tractable microorganisms, among
which Escherichia coli is the most common. It is critical toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to the target metabolite (i.e. 1-propanol) heterologously
produced in a non-native microbial host. For example,
Atsumi et al., [2] devised a synthetic approach to convert
2-ketobutyrate to produce 1-propanol in a genetically
engineered E. coli strain through a non-fermentative bio-
synthetic pathway mediated by a promiscuous 2-ketoacid
decarboxylase and an aldehyde/alcohol dehydrogenase
(ADH). The conversion bioprocess was further enhanced
using an evolved citramalate pathway [6]. On the other
hand, Choi et al., [7] demonstrated the production of 1-
propanol by grafting a pathway containing several key genes
for further conversion of L-threonine into 1-propanol in an
engineered L-threonine overproducing E. coli strain. Jain
and Yan [5] reported the production of 1-propanol in E. coli
by expanding the 1,2-propanediol pathway with two steps
mediated by a novel 1,2-propanediol dehydratase and an
ADH. More recently, Shen and Liao [8] combined the
native threonine pathway and a heterologous citramalate
pathway for synergistic production of 1-propanol in E. coli.
In addition to the aforementioned E. coli platforms, Deng
and Fong [9] explored direct conversion of untreated plant
biomass to 1-propanol using an engineered Thermobifida
fusca strain.
Herein, we present an alternative novel biosynthesis of
1-propanol by manipulating the sleeping beauty mutase
(Sbm) operon in E. coli. This four-gene operon (sbm-
ygfD-ygfG-ygfH) encodes various enzymes involved in a
cobalamin-dependent metabolic pathway for decarboxyl-
ation of succinate into propionate [10]. The metabolic
context of the Sbm-pathway remains ambiguous, but is
suspected to be involved in the assimilation of unusual
carbon sources, such as succinate and propionate. More-
over, eponymous to its name, the operon genes are hardly
expressed possibly due to an inactive or weak promoter-
operator system [11,12]. Three of the encoded proteins
from this operon are identified to be members of the cro-
tonase superfamily, namely (1) sbm encoding a cobalamin-
dependent methylmalonyl-CoA mutase (or Sbm; sleeping
beauty mutase), which catalyzes the isomerization of
succinyl-CoA to L-methylmalonyl-CoA; (2) ygfG encoding a
methylmalonyl-CoA decarboxylase (YgfG), which catalyzes
the decarboxylation of methylmalonyl-CoA to propionyl-
CoA; and (3) ygfH encoding a propionyl-CoA::succinate
transferase (YgfH) [13]. The ygfD gene encodes a putative
protein kinase (YgfD/ArgK) whose function remains un-
clear. However, YgfD could potentially interact with Sbm
to form a multi-subunit complex [14]. Although the struc-
ture, function, and relationship of these enzymes have
been characterized, hardly any work has been performed
for their practical application.
In this study, we demonstrated the production of 1-
propanol using engineered E. coli strains with an activated
Sbm operon for extended dissimilation of succinate (seeFigure 1 for relevant pathways). First, three E. coli genes of
sbm, ygfD, and ygfG were assembled as a single operon and
then were expressed to convert succinyl-CoA to propionyl-
CoA. Second, the genes encoding bifunctional ADHs from
various microorganisms were cloned and expressed to con-
vert propionyl-CoA to 1-propanol. We further channeled
carbon flux towards the 1-propanol-producing pathway
by expressing sucCD (encoding succinyl-CoA synthetase)
from E. coli. These biosynthetic strategies were imple-
mented into E. coli based on the construction of triple-
plasmid expression systems (Figure 2) to facilitate the
evaluation of suitable pathways. The 1-propanol-producing
capacity of these metabolically engineered E. coli strains
were evaluated under anaerobic cultivation conditions.
The exometabolome of the culture was analyzed using
1-dimensional hydrogen nuclear magnetic resonance (1D-
1H-NMR) spectroscopy with more than thirty metabolites
being identified. In addition, we investigated several genetic
and chemical effects associated with 1-propanol produc-
tion in engineered E. coli.
Results
Construction of propanogenic E. coli strains for 1-
propanol production
Based on the proposed novel pathway for the production of
1-propanol (Figure 1), the intracellular pool of propionyl-
CoA, a rare metabolite in E. coli, should be first increased
to promote its subsequent conversion to 1-propanol. To do
this, genes encoding methylmalonyl-mutase (Sbm), arginine
kinase (YgfD/ArgK), and methylmalonyl-CoA decarbo-
xylase (YgfG) from the Sbm operon were cloned and
expressed under the control of the Plac promoter from
plasmid pK-scpAKB. To convert the increased pool of
propionyl-CoA to 1-propanol, the gene encoding a com-
mon bifunctional ADH from C. acetobutylicum was cloned
and expressed under the control of the Plac promoter from
plasmid pU-adhE2(CA). While the wild-type strain of
BW25141 showed no sign of propionate or 1-propanol pro-
duction, approximately 47 mg/L of 1-propanol was de-
tected for WT-adhE2(CA)2 when glucose was used as the
sole carbon source (Table 1), implying that the imple-
mented 1-propanol production pathway was functioning.
A potential factor limiting the overall production of 1-
propanol was perceived to be the abundance of various pre-
cursors, such as succinate and succinyl-CoA. To investigate
this, the gene encoding E. coli succinyl-CoA synthetase
(sucCD) gene was cloned and expressed under the control
of the ParaB promoter from plasmid pB-sucCD. Compared
to WT-adhE2(CA)2, a significant increase in both propion-
ate and 1-propanol production was observed for WT-
adhE2(CA)3 (Table 1), implying that the conversion cata-
lyzed by succinyl-CoA synthetase can limit the production
of 1-propanol under shake flask culture conditions . On the
































































adhE (E.C.), adhE1 (C.A.), adhE2 (C.A.), adhP (E.C), bdhB (C.A.), yqhD (E.C.)






























Figure 1 The genetically engineered central metabolic pathway under anaerobic conditions showing the activation of the Sbm operon
(sbm, ygfD, and ygfG), and the expression of various adhEs used in this study. Red colored gene names above or beside dashed lines
represent diverting pathways; metabolites in red boxes are unwanted. Genes in green represent the necessary genes for 1-propanol conversion
from glucose; those that are in bold font and boxed represent genes expressed via episomal plasmids.
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succinate was supplemented in the cultivation medium
(Table 1), implying that succinate could also be a key pre-
cursor limiting 1-propanol production.
To further characterize this pathway, we investigated
the dispensability of YgfD/ArgK, a gene product from
the Sbm operon, for 1-propanol production. To do this,
we excised the YgfD/ArgK coding region from plasmid
pK-scpAKB. The resulting plasmid pK-scpAB was usedto replace pK-scpAKB in WT-adhE2(CA)3 to form WT-
adhE2(CA)3-ΔygfD. While 1-propanol production was
detected in the WT-adhE2(CA)3-ΔygfD culture, the titer
was approximately one third that of WT-adhE2(CA)3
(Table 1). Interestingly, the propionate concentrations
from the two strains of WT-adhE2(CA)3 and WT-adhE2
(CA)3-ΔygfD were approximately the same. From these
results, we assume that the presence of YgfD/ArgK can

































Figure 2 A schematic representation of the triple-plasmid
expression systems utilized for 1-propanol production. All
strains have (A) sbm-ygfD-ygfG cloned into pK184 under the control
of plac as well as, (B) sucCD cloned into pBBR1MCS-3 under the
control of the arabinose inducible paraB. In addition to these, each
strain has (C) pUC19 containing one of the seven listed alcohol
dehydrogenases. The red star in the adhEMUT(EC) represents the
E (glu)→K (lys) mutation at amino acid residue 568.
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As mentioned above, the production of 1-propanol can be
limited by the structural rearrangement of succinyl-CoA
into L-methylmalonyl-CoA. The catalytic activity of the
enzyme responsible for this conversion, Sbm, is dependent
on the availability of cyanocobalamin [15]. While E. coli
encodes several cobalamin-dependent mutases and pos-
sesses receptors specifically for uptake of vitamin B12
(which is the active form of cyanocobalamin) [16], the
organism neither produce cyanocobalamin in vivo nor
require it for cell growth [17]. Using WT-adhE2(CA)3 as
the host/vector system, it was observed that 1-propanol
can be produced only when a threshold concentration of
cyanocobalamin of 0.2 μM was supplemented in the culti-
vation medium. Using several cyanocobalamin concentra-
tions less than 0.2 μM either significantly reduced or even
abolished 1-production (Figure 3). As a result, this cya-
nocobalamin concentration of 0.2 μM was used for all
cultivations.
Studies were conducted to investigate the effects of
various operating parameters on cultivation perform-
ance, particularly 1-propanol titer. WT-adhE2(CA)3 was
grown aerobically and then resuspended in five different
optical cell densities for anaerobic fermentation and 1-
propanol production. Typical major fermentation metab-
olites, including ethanol, lactate, and acetate, as well
as those relevant to the proposed pathway, including
succinate, 1-propanol, and propionate, were detected in
extracellular medium samples and their titer distribu-
tions under various culture conditions are summarized
in Figure 4. While the distribution of two major metabo-
lites of acetate and lactate appears to be affected by sus-
pension cell density, the sum of their titers remained
rather constant at approximately 8 g/L. Such high levels
of major metabolites can potentially inhibit cell growth
during anaerobic fermentation. Interestingly, the titer of
the other major metabolite ethanol was minimally
affected by suspension cell density by maintaining at
approximately 2 g/L. Metabolites associated with the
1-propanol-producing pathway were considered minor
and their titer distribution was also affected by suspen-
sion cell density. 1-Propanol titer reached a peak level at
approximately 150 mg/L when suspension cell density
was higher than 10 OD600. Considering the above ef-
fects, suspension cell density at 25 OD600 was chosen
for all characterization experiments in this study. In
addition to HPLC analysis, metabolites of interest were
also analyzed by NMR, either qualitatively or quantita-
tively, based on their unique spectral signature and the
results of a representative culture sample are summa-
rized in Figure 5. In particular, the spectral signature as-
sociated with 1-propanol, i.e. the three peak clusters,
was mapped to verify the production of 1-propanol
(Figure 5C).
Table 1 1-Propanol and other metabolite titers (mg/L) in reduced M9 minimal media using E. coli strain BW25141
transformed with appropriate plasmids
Strain Carbon source Metabolite titers (mg/L)
Succinate Lactate Acetate Propionate Ethanol 1-Propanol
Control
BW25141 Glucose 307 ± 36 128 ± 11 4436 ± 250 — 3021 ± 156 —
Experimental
WT-adhE2(CA)2 Glucose 264 ± 8 2601 ± 642 2961 ± 72 Trace 2640 ± 170 47 ± 2
WT-adhE2(CA)3 Glucose 231 ± 11 1877 ± 303 2653 ± 55 51 ± 14 3199 ± 283 103 ± 16
WT-adhE2(CA)3 Glucose and succinate 2200 ± 172 2293 ± 2970 3699 ± 352 123 ± 21 2774 ± 297 168 ± 39
WT-adhE2(CA)3-ΔygfD Glucose 269 ± 94 3970 ± 1367 2527 ± 142 52 ± 8 1999 ± 104 37 ± 1
Cultures were induced at an O.D600 of 15. Strains were cultivated anaerobically at 37°C for 72 h. Carbon sources: 20 g/L glucose and 4 g/L succinate where
indicated. All experiments were performed in triplicate.
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Based on reported biosynthetic pathways of several alco-
hols (particularly long-chain alcohols) [18,19], the se-
quential reduction of propionyl-CoA to propionaldehyde
and then to 1-propanol via a bifunctional ADH can rep-
resent a key step limiting the overall production of 1-
propanol. In addition to C. acetobutylicum bifunctional
ADH (AdhE2), various other ADHs were investigated in
this study. E. coli has several ADHs, including AdhE,
AdhP, YqhD, EutG, and YiaY [18]. To evaluate the ef-
fects of these endogenous ADHs on 1-propanol produc-
tion, an E. coli strain of WT2, similar to WT-adhE2(CA)3
but without episomal expression of AdhE2, was de-
rived. This strain, though harboring its native ADHs,
failed to produce any detectable amount of 1-propanol

























Figure 3 The effect of cyanocobalamin concentration on 1-propanol
dependent on the exogenous supplementation of cyanocobalamin and sa
anaerobically in reduced M9 minimal media with 20 g/L of glucose at 37°Csuggest that 1-propanol production was primarily medi-
ated by C. acetobutylicum AdhE2 in WT-adhE2(CA)3. In
principle, 1-propanol should be detected in WT2, since
bioinformatics databases such as BRENDA [20] report
that certain E. coli ADHs also possess affinity for either
propionyl-CoA and/or propionaldehyde as potential sub-
strates. The abolishment of 1-propanol production in
WT2 may be attributed to the very low basal levels of the
native ADHs present in the cell with higher affinities for
other substrates.
To further study the effects of various E. coli ADHs on
1-propanol production, we respectively cloned the adhE,
adhP, and yqhD genes for episomal expression (Figure 2)
and the results are summarized in Table 2. Amongst the
native ADHs, YqhD and AdhP were of particular inter-
est because of their affinity for medium-to-long chain0.2 0.4
n concentration (µM)
production in strain WT-adhE2(CA)3. 1-Propanol production is
turation occurs at concentrations above 0.2 μM. Strains were cultivated
for 72 h. All experiments were performed in triplicate.
Figure 4 End point secretion profile of major end products
from anaerobic fermentations of WT-adhE2(CA)3 at five optical
densities (OD600), profiled by 1D-1H-NMR. Major end products
that are competitor metabolites to the production of 1-propanol are
quantified by the left axis. Products detected along the desired
metabolic pathway towards formation of 1-propanol are quantified
by the right axis. Strain was cultivated anaerobically in reduced M9
minimal media with 20 g/L of glucose at 37°C for 72 h.
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WT-adhP(EC) and WT-yqhD(EC) cultures were ~25%
less than that in WT-adhE2(CA)3. Note that both YqhD
and AdhP are unifunctional ADHs and thus lack an
acetaldehyde dehydrogenase domain at the carboxyl end.
The bifunctional AdhE of E. coli (encoded by the adhE
gene) was also evaluated. However, the plasmid con-
taining the E. coli adhE gene cannot be transformed into
E. coli cells since episomal expression of the endogenous
AdhE appears to be physiologically toxic. To circumvent
this limitation, we derived an aerotolerant mutant of
AdhE, which was previously documented to be less toxic
to E. coli cells [21], and the corresponding propanogenic
strain, i.e. WT-AdhEMUT(EC), could produce 1-propanol,
but only at a level similar to WT-adhP(EC) and WT-
yqhD(EC) (Table 2). These results suggest that the ac-
tivities of E. coli ADHs towards propionyl-CoA or
propionaldehyde are less than C. acetobutylicum AdhE2
under similar cultivation conditions. Moreover, the utili-
zation of a unifunctional or bifunctional ADH seems
to have no major effects on 1-propanol biosynthesis.
In addition to AdhE2, two alternative ADHs from C.
acetobutylicum, i.e. AdhE1 and BdhB, which are involved
in butanol production during Clostridia solventogenesis
phase [22], were examined for their effects on 1-propanol
production using WT-adhE1(CA) and WT-bdhB(CA)
(Table 2). The 1-propanol titer of the WT-adhE1(CA)
culture was ~25% lower than that of WT-adhE2(CA)3,
whereas WT-bdhB(CA) demonstrated a 1-propanol cap-
acity similar to WT-adhE2(CA)3 (Table 2). The results
suggest that 1-propanol biosynthesis in E. coli can bemediated by a variety of ADHs and the intracellular levels
of these ADHs appear to be critical to drive 1-propanol
production under shake flask culture conditions.
Effects of host-gene deletions on 1-propanol production
While 1-propanol production based on this novel path-
way in E. coli is feasible, the titer and yield can be poten-
tially limited by the accumulation of major metabolites
of lactate, acetate, and ethanol (Figure 4). Hence, we also
explored deletion of several host genes involved in the
production of these metabolites, specifically adhE en-
coding AdhE, pta encoding phosphotransacetylase, and
ldhA encoding lactate dehydrogenase, and the results
are summarized in Table 3. Deletion of adhE (in WT-
ΔadhE) reduced the production of ethanol significantly
compared to wild-type BW25141. However, the 1-
propanol-producing capacity of WT-ΔadhE appears to be
completely abolished, even after being transformed with
the triple-plasmid expression system for activation of the
Sbm pathway (data not shown). On the other hand, delet-
ing pta (in WT-Δpta) resulted in marked growth retard-
ation though the acetate levels were significantly reduced,
compared to wild-type BW25141, with the main fer-
mentative byproduct being lactate. Similar to WT-ΔadhE,
WT-Δpta was also incapable of producing 1-propanol
when being transformed with the triple-plasmid expres-
sion system (data not shown). Deletion of ldhA (in WT-
ΔldhA) significantly reduced lactate titers, with superior
cell growth compared to wild-type BW25141 under aer-
obic conditions. In contrast to the previous two mutant
strains, WT-ΔldhA retained the 1-propanol-producing ca-
pacity upon its transformation with the triple-plasmid ex-
pression system. Nevertheless, the 1-propanol titers for
these expression systems were approximately half of that
for WT-adhE2(CA)3 (Table 3). Note that both ethanol
and acetate titers for these WT-ΔldhA expression systems
were significantly higher than WT-adhE2(CA)3, implying
that the carbon flux was not properly channeled into the
1-propanol-producing pathway. Furthermore, while WT-
ΔldhA expression systems were competent producers of
1-propanol, certain double (i.e. ΔldhA ΔadhE) and triple
mutant (i.e. ΔldhA ΔadhE Δpta) counterparts failed to
produce the target metabolite under shake flask culture
conditions (data not shown).
Discussion
To date, metabolic engineering of E. coli for 1-propanol
biosynthesis has been conducted through two major path-
ways, i.e. (1) the keto-acid biosynthetic pathway [6-8] and
(2) the extended 1,2-propanediol pathway [5]. Unlike these
approaches, our strategy focused on activation of the
endogenous but often silent Sbm operon for extended
conversion of succinate into 1-propanol. The 1-propanol-
producing capacity was implemented by transforming a
Figure 5 Single dimension hydrogen NMR spectra scanned at 600 MHz from samples of E. coli supernatant from strain WT-adhE2(CA)3.
Strain was cultivated anaerobically in reduced M9 minimal media with 20 g/L of glucose at 37°C for 72 h. Culture samples were then centrifuged
for 3 min at 13,000 × g to recover the supernatant fraction for analysis. A) The 25 OD600 spectrum profiled for metabolites using Chenomx Suite
7.5. B) Zoomed in panels from part A, identifying the three peak clusters of 1-propanol and major end-product metabolites. From left to right the
panels show: i. lactate, glucose and ethanol peaks, ii. convolution of glycine spectra with that of the first 1-propanol peak cluster, iii. acetate, iv.
the unobscured second peak cluster of 1-propanol, v. propionate, vi. the third peak cluster of 1-propanol. C) Zoomed in panels from part B of the
three 1-propanol peak clusters from pure solution standard and supernatant of WT-adhE2(CA)3 grown at 25 OD600.
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spectively harboring the Sbm operon genes (with the
exception of ygfG), sucCD, and adhE2 for expression of
these key genes. Using the metabolically engineered strains
for anaerobic fermentation, we obtained 1-propanol titers
up to 150 mg/L which is comparable to those of other
studies [5,9]. In addition, we identified several potentialfactors limiting 1-propanol production, in particular the
abundance of precursors and the conversion step catalyzed
by a bi-functional alcohol/aldehyde dehydrogenase. While
it is possible to perform this biotransformation aerobically,
anaerobic cultivation was chosen for two reasons. Firstly,
the two TCA intermediates of succinate and succinyl-CoA
are the precursors for 1-propanol biosynthesis and their
Table 2 Comparison of 1-propanol production titers and other metabolites (mg/L) by expression of several ADHs in
E. coli strain BW25141, transformed with appropriate plasmids
Strain Metabolite titers (mg/L)
Succinate Lactate Acetate Propionate Ethanol 1-Propanol
Control
BW25141 307 ± 36 128 ± 11 4436 ± 250 — 3021 ± 156 —
Experimental
WT-adhE2(CA)3 231 ± 11 1877 ± 303 2653 ± 55 51 ± 14 2774 ± 297 103 ± 16
WT-adhP(EC) 239 ± 57 2986 ± 498 2545 ± 89 100 ± 18 3192 ± 80 84 ± 7
WT-yqhD(EC) Trace 3322 ± 920 3818 ± 826 29 ± 67 3469 ± 538 69 ± 10
WT-adhEMUT(EC) Trace 3762 ± 393 2164 ± 64 Trace 4016 ± 83 74 ± 6
WT-adhE1(CA) Trace 411 ± 120 4247 ± 198 71 ± 10 4397 ± 403 76 ± 11
WT-bdhB(CA) 150 ± 131 2139 ± 474 2329 ± 21 67 ± 22 3455 ± 169 109 ± 6
Cultures were suspended in reduced M9 minimal media and induced at an O.D600 of 15. Strains were cultivated anaerobically at 37°C for 72 h. Glucose (20 g/L)
was used as the sole carbon source and all experiments were performed in triplicate.
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Under anaerobic, but not aerobic, conditions, E. coli gener-
ates both succinate and succinyl-CoA as fermentation end
products via a reductive reverse TCA pathway (Figure 1).
Secondly, potential oxygen-sensitivity of AdhE2 and other
ADHs is another limitation for oxygenic production of 1-
propanol.
While the expression of enzymes encoded by the Sbm
operon is potentially detectable, their levels are far too
low to form a functional pathway [13,14,23]. Moreover,
due to E. coli’s inability to produce coenzyme B12, the
expressed Sbm remains as an inactive apo-enzyme, but
nano-molar supplementation of cyanocobalamin can result
in the formation of active Sbm [24,25]. Our observations ofTable 3 Secretion profile of the metabolites produced (mg/L)
plasmids
Strain Metabolite titers (mg/L)
Succinate Lactate Aceta
Controls
BW25141 307 ± 36 128 ± 11 4436 ±
WT-ΔadhE Trace 99 ± 17 4646 ±
WT-Δpta 776 ± 57 7259 ± 14 694 ±
WT-ΔldhA 187 ± 7 195 ± 14 3960 ±
Experimental
WT-adhE2(CA)3 231 ± 11 1877 ± 303 2653 ±
ΔldhA- adhE(EC) 206 ± 49 63 ± 3 4181 ±
ΔldhA- adhE2(CA) 247 ± 64 77 ± 4 4210 ±
ΔldhA- adhE1(CA) 256 ± 106 81 ± 10 3696 ±
ΔldhA- adhEMUT(EC) 243 ± 8 79 ± 7 3814 ±
ΔldhA- adhP(EC) 208 ± 115 190 ± 16 4488 ±
ΔldhA-yqhD(EC) 145 ± 49 99 ± 16 4145 ±
ΔldhA- bdhB(CA) 212 ± 50 89 ± 12 4351 ±
Cultures were suspended in reduced M9 minimal media and induced at an O.D600
was used as the sole carbon source and all experiments were performed in triplicatno detectable titers of propionate and 1-propanol for
wild-type BW25141 as well as the production of 1-
propanol upon heterologous expression of the Sbm
operon genes with proper supplementation of cyano-
cobalamin was associated with the activation of the
Sbm-pathway. While the activated Sbm-pathway can re-
sult in 1-propanol production, the expression of SucCD
was deemed crucial to increase the succinyl-CoA pool
and consequently the 1-propanol titer. In addition, 1-
propanol production was enhanced by exogenous sup-
plementation of succinate. These results suggest that
1-propanol production can be limited by the availability
of various precursors and key enzymes along this 1-
propanol-producing pathway.by various knock out strains with or without appropriate
te Propionate Ethanol 1-Propanol
250 — 3021 ± 156 —
705.2 — 1936 ± 741.9 —
196 — 3927 ± 691 —
151 — 6128 ± 80 —
55 51 ± 14 2774 ± 297 103 ± 16
550 — 6209 ± 183 42 ± 4
292 — 6713 ± 270 57 ± 1
652 — 5863 ± 9 45 ± 10
26 — 6021 ± 104 60 ± 9
126 — 6124 ± 119 65 ± 2
14 — 5732 ± 77 38 ± 1
204 — 5652 ± 195 41 ± 4
of 15. Strains were cultivated anaerobically at 37°C for 72 h. Glucose (20 g/L)
e.
Srirangan et al. Biotechnology for Biofuels 2013, 6:139 Page 9 of 14
http://www.biotechnologyforbiofuels.com/content/6/1/139While the metabolic context for the three enzymes
encoded by the four-gene Sbm operon, i.e. Sbm, YgfG, and
YgfH, has been unraveled, the biological role of the other
member, i.e. YgfD/ArgK, remains ambiguous. Earlier stud-
ies determined that YgfD/ArgK is a putative arginine kin-
ase interacting with Sbm in vivo and in vitro [14] and
involved in the phosphorylation of periplasmic binding
proteins for amino acid translocation [11]. The activity of
YgfD/ArgK was shown to be potentially essential for 1-
propanol biosynthesis since the 1-propanol titer was sig-
nificantly reduced by the ygfD/argK deletion. Interestingly,
propionate production was hardly affected by the ygfD/
argK deletion, and this result is consistent with a previous
report [26], where propionate was derived from fatty acids
by expressing the Sbm-operon genes excluding ygfD/argK
in an engineered E. coli strain.
A selection of native and non-native ADHs were heter-
ologously expressed for evaluation of their effects on 1-
propanol-producing capacity of various metabolically en-
gineered E. coli strains, with AdhE2 and BdhB being
identified as the most prominent ones for 1-propanol pro-
duction. Nevertheless, our consistent observation that
ethanol titers were significantly higher than 1-propanol
implies that propionyl-CoA or propionaldehyde might
have less affinity towards ADHs than acetyl-CoA or acet-
aldehyde. Several native E. coli ADHs (e.g. YqhD, AdhP,
and AdhEMUT) were also active in driving 1-propanol pro-
duction, but in a much lower titer. In particular, the gener-
ation of the aerotolerent AdhE mutant (AdhEMUT) opens
an avenue for aerobic production of 1-propanol. Under
anaerobic conditions, the maximum theoretical yield (on
the molar basis) of 1-propanol from glucose is less than
one due to limited NADH availability. Thus, developing
an oxygenic production system would be beneficial as it
increases the carbon throughout whilst improving cell
growth and physiology.
Under anoxic conditions for anaerobic fermentation in
E. coli, the carbon flux at the PEP node favors reduction
into pyruvate rather than carboxylation into oxaloacetate
(OAA), with lactate, acetate, and ethanol as major
metabolites (Figure 1). Note that there are four NADH-
consuming steps along the 1-propanol-producing path-
way downstream of phosphoenolpyruvate (PEP), whereas
only one or two NADH-consuming steps for the other
pathways associated with the major metabolites. The
anaplerotic reactions within the metabolic network are
optimized in order to balance the cell’s energy budget
and electrons. Consequently, only ~10% of glucose con-
sumed is channeled towards succinate and cell mass
[27]. Our results suggest that the production of 1-
propanol was potentially hampered by the inherent
limitation in succinate production and a metabolic defi-
ciency in NADH generation. Interestingly, propionate
was also concomitantly produced with 1-propanol in ourmetabolically engineered strains (Tables 1 and 2). Add-
itional studies are needed to elucidate the dichotomy be-
tween 1-propanol and propionate accumulation.
There is an apparent need to reduce the amounts of
major metabolites, i.e. ethanol, acetate, and lactate. This
could be achieved by knocking out relevant native genes
in the hope to redirect the carbon flux into the 1-
propanol-producing pathway. While deletions of both
adhE and pta were previously found to improve succin-
ate titers [28], these mutations abolished 1-propanol
production in our study (data not shown). Deletion of
pta resulted in the channeling of the carbon flux to-
wards lactate accumulation. In addition, heterologous
expression of E. coli AdhE or other ADH homologs
failed to complement the adhE genomic knockout in
terms of restoring 1-propanol production, potentially
due to unknown perturbations in the metabolite pool or
gene regulation. While the lactate level was significantly
reduced for the ldhA null mutants, they produced con-
siderable levels of both acetate and ethanol, thus redu-
cing the carbon flux towards 1-propanol production
(Table 3). Nonetheless, the ldhA mutation was deemed
beneficial since it offers an additional NADH source and
greatly reduces the acidification of the medium, thus im-
proving cell growth.
Another critical factor limiting the production of 1-
propanol (and other desired metabolites, such as succinate
[28] and malate [29]) is the energetically favored diversion
of carbon flux at the node of PEP towards pyruvate,
resulting in the production of the major metabolites etha-
nol, lactate, and acetate. Blocking the production of one of
these major metabolites (i.e. lactate, acetate, or ethanol)
causes the accumulation of the others without improving
the overall production of 1-propanol since these major
metabolites all share the same precursor of pyruvate.
Therefore, the implementation of a “driving force” divert-
ing the carbon flux from pyruvate to OAA appears to be
inevitable. Several metabolic engineering strategies to im-
prove this are currently under our investigation Since a
considerable amount of succinate accumulated in the
extracellular medium potentially due to the poor affinity
of succinate to SucCD (Km of ~0.25 mM with succinyl-
CoA as the substrate in comparison to Km of ~4 mM with
succinate as the substrate [30]), we are also identifying
novel succinyl-CoA synthethases with a higher affinity
for succinate to alleviate this limitation in 1-propanol
production.
Conclusions
In this study, we demonstrated the manipulation of the
homologous Sbm operon for extended dissimilation of
succinate in E. coli, leading to 1-propanol production.
Using the engineered E. coli strains for anaerobic culti-
vation in a shaker, 1-propanol titers up to 150 mg/L
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represented the major metabolites, potentially limiting
the productivity of 1-propanol. To improve the efficiency
and applicability of this biocatalytic system, further stud-
ies have to be conducted to derive superior production
strains by eliminating key conversion bottlenecks, meta-
bolic imbalances, and undesirable byproducts as well as
to optimize gene expression and culture conditions.
Methods
Plasmid construction
All plasmids and primers used in this study are listed in
Table 4. Genomic DNA from various bacterial strains was
isolated using the Blood & Tissue DNA Isolation Kit
(Qiagen, Hilden, Germany). Standard recombinant DNA
technologies for gene cloning [31] were applied. Various
DNA polymerases, restriction endonucleases, T4 DNA lig-
ase, and Antarctic phosphatase were obtained from New
England Biolabs (Ipswich, MA). All oligonucleotides were
obtained from Integrated DNA Technologies (Coralville,
IA). DNA sequencing was conducted in the Centre for Ap-
plied Genomics at the Hospital for Sick Children (Toronto,
Canada).
The succinyl-CoA synthetase gene (sucCD) from E.
coli was cloned into the plasmid pBBR1MCS-3 for its
expression under the regulation of the inducible ParaB
promoter. To make this construct, sucCD was PCR-
amplified from E. coli BW25141 genomic DNA using
the c-sucCD primer set, whereas the araC-ParaB frag-
ment was PCR-amplified from pKD46 using the c-paraB
primer set. The two DNA fragments were then tran-
scriptionally fused with splice overlap extension PCR
[37] using the forward primer c-paraB and the reverse
primer c-sucCD. The resulting araC-ParaB::sucCD frag-
ment was directionally cloned into the XhoI and XbaI
restriction sites of pBBR1MCS-3, yielding pB-sucCD.
The fusion containing the three genes of sbm-ygfD-ygfG
from the Sbm operon was PCR-amplified from E. coli
BW25141 genomic DNA using the c-scpAB primer set.
The amplified DNA fragment was non-directionally cloned
into the EcoRI restriction site of pK184. A clone with the
correct transcriptional orientation of the sbm-ygfD-ygfG
fragment with respect to the inducible Plac promoter was
selected and verified by DNA sequencing, yielding pK-
scpAKB. To test the essentialness of YgfD/ArgK, PCR was
used to amplify the entire pK-scpAKB construct, with
the exception of ygfD, using the c-argK primer set. This
resulted in the addition of a flanking XbaI site downstream
of sbm and upstream of ygfG. XbaI digestion and relegation
of this PCR product rendered plasmid pK-scpAB.
A selection of genes encoding alcohol/aldehyde dehy-
drogenases from various sources were respectively cloned
into pUC19 as transcriptional fusions under the control of
the inducible Plac promoter. To do this, the adhE, ydhD,and adhP genes were amplified from E. coli BW25141
genomic DNA using the c-adhE(EC), c-yqhD(EC), and
c-adhP(EC) primer sets, respectively. The resulting PCR
products were individually fused with the BamHI-
linearized pUC19 using the In-Fusion PCR Cloning Sys-
tem (Clonetech Laboratories Inc., Mountainview, CA) to
yield pU-adhE(EC), pU-yqhD(EC), and pU-adhP(EC), re-
spectively. Similarly, the adhE2, adhE1, and bdhB genes
were PCR-amplified from Clostridium acetobutylicum
ATCC 824 genomic DNA using the c-adhE2(CA), c-
adhE1(CA), and c-bdhB primer sets, respectively. The
resulting PCR products were individually fused with
the BamHI-linearized pUC19 to yield pU-adhE2(CA),
pU-adhE1(CA), and pU-bdhB(CA), respectively. Plasmid
pU-adhEMUT(EC) was derived from pU-adhE(EC) by gen-
erating a Glu568Lys mutation within the adhE coding se-
quence using the Phusion Site-directed Mutagenesis Kit
(New England Biolabs) with the m-adhE primer set and the
point-mutation was screened based on the loss of a unique
SapI restriction site. Similar to a previous approach [26],
pU-adhEMUT(EC) was used to express an aero-tolerant
E. coli alcohol/acetaldehyde dehydrogenase mutant.
Bacterial strains and chromosomal manipulation
A selection of E. coli host strains and host/vector systems
used in this study are listed in Tables 4 and 5, respectively.
BW25141 was used to provide wild-type (WT) genetic
backgrounds for 1-propanol production. HST08 was used
for molecular cloning. Various host gene deletions (e.g.
adhE, pta, and ldhA) were introduced to BW25141 by
P1-phage transduction [31] using proper Keio Collection
strains (CGSC, Yale University) as donors [38]. The co-
transduced KmR-FRT gene cassette was removed using
pCP20 [33]. E. coli strain MC4100 was used as a control
strain for all P1 phage transductions. The genotypes of de-
rived knockout strains were confirmed with colony PCR
using appropriate primer sets (e.g. v-adhE, v-pta, and v-
ldhA).
Media and cultivation
All chemicals for medium components were obtained from
Sigma-Aldrich Co. (St Louis, MO) except yeast extract and
tryptone, which were obtained from BD Diagnostic Sys-
tems (Franklin Lakes, NJ). When required, antibiotics at a
proper concentration were used: 100 μg/mL carbenicillin,
50 μg/mL kanamycin, and 20 μg/mL tetracycline. For
multi-plasmid systems, the concentration of each antibiotic
was reduced to half to avoid negative impacts on growth.
Isopropyl-beta- D-thiogalactopyranoside (IPTG) (1 mM)
and L-arabinose (10 mM) were used to induce gene
expression respectively regulated by the Plac and ParaB
promoters.
For all cultivation experiments, E. coli strains (stored
as glycerol stocks at −80°C) were streaked on LB plates
Table 4 Hosts strains, plasmids and primers
Name Description, relevant genotype or primer sequence (5′→ 3′) Reference
E. coli host strains
HST08 F-, endA1, supE44, thi-1, recA1, relA1, gyrA96, phoA, Φ80d lacZΔM15, Δ(lacZYA – argF) U169,
Δ(mrr – hsdRMS – mcrBC), ΔmcrA, λ–
Takara Bio, Shiga,
Japan
MC4100 F-, [araD139]B/r, Del(argF-lac)169, λ–-, e14-, flhD5301, Δ(fruK-yeiR)725(fruA25), relA1, rpsL150(strR),
rbsR22, Del(fimB-fimE)632(::IS1), deoC1
[32]
BW25141 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), Δ(phoB-phoR)580, λ-, galU95, ΔuidA3::pir+, recA1,
endA9(del-ins)::FRT, rph-1, Δ(rhaD-rhaB)568, hsdR514
[33]
BW25113 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514 [33]
WT-ΔadhE adhE null mutant of BW25113 This study
WT-ΔldhA ldhA null mutant of BW25113 This study
WT-Δpta pta null mutant of BW25113 This study
Plasmids
pCP20 FLP+, λ cI857+, λ pR Rep(pSC101 ori)ts, ApR, CmR [34]
pKD46 RepA101ts, ApR, araC-ParaB::gam-bet-exo [33]
pK184 p15A ori, KmR, Plac::lacZ’ [35]
pBBR1MCS-3 broad host range ori, TcR, Plac::lacZ’ [36]
pUC19 ColE1 ori, ApR, Plac::lacZ’ Invitrogen, Corp.,
Carlsbad, CA
pK-scpAKB From pK184, Plac:: sbm-ygfD-ygfG This study
pK-scpAB From pK184, Plac:: sbm-ygfG This study
pB-sucCD From pBBR1MCS-3, araC-ParaB::sucCD This study
pU-adhE(EC) From pUC19, Plac::adhE(EC) This study
pU-adhE2(CA) From pUC19, Plac::adhE2(CA) This study
pU-adhE1(CA) From pUC19, Plac::adhE1(CA) This study
pU-adhEMUT(EC) From pUC19, Plac::adhE Glu568Lys(EC) This study
pU-adhP(EC) From pUC19, Plac::adhP(EC) This study
pU-yqhD(EC) From pUC19, Plac::yqhD(EC) This study
Primers
v-adhE AATCTTGCTTACGCCACCTGGAAGTG; CGAACGGTCGCATGAGCAGAAAGCG This study
v-pta GGCATGAGCGTTGACGCAATCAACA; GATCCTGAGGTTAATCCTTCAAACG This study
v-ldhA TCATCAGCAGCGTCAACGGC; ATCGCTGGTCACGGGCTTACCGTT This study
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Primer notation is as follows: v- knockout primer, m- mutagenic primer and c- cloning primer. Underlined sequences within the primers denote restriction sites.
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37°C. Single colonies were picked from LB plates to in-
oculate 25-mL LB media with appropriate antibiotics in
125-mL conical flasks. The cultures were grown in a ro-
tary shaker at 250 rpm and 37°C to reach an optical cell
density at 600 nm (OD600) of 0.7. Four milliliter of the
seed culture was used to inoculate 400-mL LB media
with appropriate antibiotics in 1-L conical flasks. This
second seed culture was also shaken at 250 rpm and
37°C to reach an OD600 of 0.7. Cells were collected by
centrifugation at 6,000 × g and 4°C for 20 min and the
cell pellets were transferred into a controlled anaerobic
atmosphere (85% N2, 10% H2, and 5% CO2) in an anaer-
obic chamber (Plas-Labs Inc., Lansing, MI). Cell pellets
were washed and resuspended in reduced modified M9
minimal media [6 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L
NaCl, 1g/L NH4Cl, 1 mM MgSO4, 0.1 mM CaCl2, 10
mM NaHCO3, 10 mg/L vitamin B1, and 0.2 μM cyano-
cobalamin (vitamin B12)] containing appropriate carbon
sources, 5 g/L yeast extract, appropriate antibiotics andTable 5 E. coli strains containing variants of the synthetic
1-propanol pathway used in this study
Strain E. coli
host
Plasmid 1 Plasmid 2 Plasmid 3
WT2 BW25141 pK-scpAKB pB-sucCD —
WT-adhE2(CA)2 BW25141 pK-scpAKB — pU-adhE2(CA)
WT-adhE2(CA)3 BW25141 pK-scpAKB pB-sucCD pU-adhE2(CA)
WT-adhE2(CA)3-
ΔygfD
BW25141 pK-scpAB pB-sucCD pU-adhE2(CA)
WT-adhE1(CA) BW25141 pK-scpAKB pB-sucCD pU-adhE1(CA)
WT-adhEMUT(EC) BW25141 pK-scpAKB pB-sucCD pU-adhEMUT(EC)
WT-adhP(EC) BW25141 pK-scpAKB pB-sucCD pU-adhP(EC)
WT-yqhD(EC) BW25141 pK-scpAKB pB-sucCD pU-yqhD(EC)
WT-bdhB(CA) BW25141 pK-scpAKB pB-sucCD pU-bdhB(CA)
ΔldhA-adhE(EC) WT-ΔldhA pK-scpAKB pB-sucCD pU-adhE(EC)
ΔldhA-adhE2(CA) WT-ΔldhA pK-scpAKB pB-sucCD pU-adhE2(CA)
ΔldhA-adhE1(CA) WT-ΔldhA pK-scpAKB pB-sucCD pU-adhE1(CA)
ΔldhA-adhEMUT (EC) WT-ΔldhA pK-scpAKB pB-sucCD pU-adhEMUT(EC)
ΔldhA-adhP(EC) WT-ΔldhA pK-scpAKB pB-sucCD pU-adhP(EC)
ΔldhA-yqhD(EC) WT-ΔldhA pK-scpAKB pB-sucCD pU-yqhD(EC)
ΔldhA-bdhB(CA) WT-ΔldhA pK-scpAKB pB-sucCD pU-bdhB(CA)inducers, and 1000X trace metal mix A5 (2.86 g/L H3BO3,
1.81 g/L MnCl2•4H2O, 0.222 g/L ZnSO4•7H2O, 0.39 g/L
Na2MoO4•2H2O, 0.079 g/L CuSO4•5H2O, 49.4 mg/L
Co(NO3)2•6H2O). Cells were resuspended to a final OD600
of 15 unless specified otherwise. While most oxygen in the
modified M9 minimal media was purged by autoclaving,
trace oxygen was reduced using a palladium catalyst at-
tached to the heating unit of the anaerobic chamber. The
anaerobic condition of the medium was monitored using
resazurin, which was added at 1 mg/L. Suspended cultures
were then transferred into 50-mL screw-capped conical
flasks and sealed with Parafilm, before being removed
from the anaerobic chamber and placed in a rotary shaker
running at 250 rpm 37°C. Cultures were unsealed and an-
alyzed after 3 d.
Analytical procedures
Culture samples were appropriately diluted with an iso-
tonic saline solution for measuring the optical cell density
(OD600) using a spectrophotometer (DU520, Beckman
Coulter, Fullerton, CA). For HPLC and NMR analyses,
culture samples were centrifuged for 3 min at 13,000 × g
to recover the supernatant fraction which was filtered with
a 0.2 μM syringe filter prior to being stored at −20°C.
HPLC analysis
Extracellular metabolites were analyzed using HPLC (LC-
10ATVP, Shimadzu, Kyoto, Japan) equipped with an
Aminex HPX87 column (BioRad Laboratories, Hercules,
CA) and a refractive index detector (RID-10A, Shimadzu,
Kyoto, Japan). The column temperature was maintained at
65°C when conducting analysis. The mobile phase was 5
mM H2SO4 (pH 2.0) running at 0.6 mL/min. The RID was
connected to an integrator (C-R8A, Shimadzu, Kyoto,
Japan) for chromatographic data processing. Pure samples
of various metabolites with concentrations ranging from
0.02 to 12.0 g/L were used as standards for calibration.
Cell-free fermentation samples were subjected to filtration
treatment prior to their injection for HPLC analysis.
NMR analysis
NMR sample preparation
Extracellular medium samples were diluted in 10% v/v
with an internal standard composed of 99.9% D2O with 5
mM 2,2-Dimethyl-2-silapentane-5-sulfonate (DSS) serving
Srirangan et al. Biotechnology for Biofuels 2013, 6:139 Page 13 of 14
http://www.biotechnologyforbiofuels.com/content/6/1/139as a chemical shape indicator (CSI) and 0.2% w/v sodium
azide (NaN3) to inhibit bacterial growth. The diluted sam-
ples were subsequently transferred to 5-mm NMR tubes
(NE-UL5-7, New Era Enterprises Inc., Vineland, NJ). Spec-
tra were acquired by a 1D NOESY pulse sequence on a
Bruker Avance 600.13 MHz spectrometer with a TXI 600
Probe (Bruker Canada Ltd., Toronto, Canada).
Spectra processing and compound identification
Following acquisition, spectra were imported into Chenomx
NMR Suite 7.5 (Chenomx Inc., Edmonton, Alberta, Canada)
for data processing with phase, baseline, shim, and shape
corrections being carried out. An average sample pH of 5.2
measured during fermentation was applied as a reference
for metabolite identification. Following spectral processing,
various extracellular metabolites were identified by targeted
profiling. Since the compound database associated with
Chenomx NMR Suite 7.5 software did not include 1-
propanol (Figure 5) or propionaldehyde, the ‘compound
builder’ application was used to implement the hydrogen
spectra and unique peaks of these compounds.
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